Pages that link to "Q27469594"
Jump to navigation
Jump to search
The following pages link to Cell fusion activity of hepatitis C virus envelope proteins (Q27469594):
Displaying 50 items.
- Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection (Q21245138) (← links)
- Analysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteins (Q24295546) (← links)
- DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 (Q24296260) (← links)
- Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein (Q24338469) (← links)
- Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR (Q24551041) (← links)
- Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating (Q24562016) (← links)
- Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor (Q27469307) (← links)
- Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment (Q27469804) (← links)
- Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles (Q27472884) (← links)
- Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins (Q27472885) (← links)
- Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry (Q27472900) (← links)
- Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81 (Q27472909) (← links)
- Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay (Q27472928) (← links)
- Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype (Q27472930) (← links)
- Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins (Q27472931) (← links)
- Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection (Q27486112) (← links)
- Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry (Q27489898) (← links)
- The impact of hepatitis C virus entry on viral tropism (Q27693297) (← links)
- Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity (Q28485983) (← links)
- Novel insights into hepatitis C virus replication and persistence (Q29620681) (← links)
- HCV infection of the transplanted liver: changing CD81 and HVR1 variants immediately after liver transplantation (Q30438047) (← links)
- Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System (Q33418872) (← links)
- Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus (Q33744103) (← links)
- Direct Binding of the Ligand PSG17 to CD9 Requires a CD9 Site Essential for Sperm-Egg Fusion (Q33763806) (← links)
- A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection (Q34009510) (← links)
- Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy (Q34016463) (← links)
- Human liver transplantation as a model to study hepatitis C virus pathogenesis (Q34197528) (← links)
- In search of hepatitis C virus receptor(s). (Q34422731) (← links)
- The challenge of developing a vaccine against hepatitis C virus (Q34979868) (← links)
- Neutralizing antibodies in hepatitis C virus infection: a review of immunological and clinical characteristics (Q35189019) (← links)
- Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. (Q35249163) (← links)
- New therapies for chronic hepatitis C virus infection (Q35628143) (← links)
- Mechanisms of hepatitis C virus infection (Q35669529) (← links)
- Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion (Q35842116) (← links)
- Cell entry of hepatitis C virus (Q36385222) (← links)
- Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41 (Q36814871) (← links)
- Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems (Q37201846) (← links)
- Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design (Q37252942) (← links)
- Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer (Q37596447) (← links)
- Exploitation of lipid components by viral and host proteins for hepatitis C virus infection (Q37986051) (← links)
- Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate (Q38352468) (← links)
- Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro. (Q39092405) (← links)
- The potential of signal peptide peptidase as a therapeutic target for hepatitis C. (Q40078310) (← links)
- Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion (Q40127843) (← links)
- Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins (Q40228962) (← links)
- Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey (Q40244787) (← links)
- Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1 (Q40344741) (← links)
- Characterization of functional hepatitis C virus envelope glycoproteins. (Q40539381) (← links)
- Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus (Q40587224) (← links)
- CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo (Q40653700) (← links)